Macrogen, Inc. (KOSDAQ:038290)
South Korea · Delayed Price · Currency is KRW 12,500
-220 (-1.73%)
Aug 12, 2026, 1:45 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 137.9 billion as of August 11, 2026. Its market cap has decreased by -20.35% in one year.
Market Cap
137.90B
Enterprise Value
190.85B
Revenue
199.60B
Ranking
n/a
PE Ratio
36.29
Stock Price
12,500.00
ChartMarket Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 137.90B, a decrease of -7.00%. That is a compound annual growth rate of -0.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 137.90B | -24.60% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 219.85B |
| EASY BIO,Inc. | 208.42B |
| HLB Therapeutics | 188.38B |
| Bioneer | 178.35B |
| Anterogen.Co.,Ltd. | 169.40B |
| JETEMA, | 162.20B |
| Helixmith | 156.56B |
| NeoImmuneTech | 151.17B |